Publication: Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
| dc.contributor.author | Nicholas J. White | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2020-01-27T08:52:36Z | |
| dc.date.available | 2020-01-27T08:52:36Z | |
| dc.date.issued | 2019-10-11 | en_US |
| dc.description.abstract | © 2019 The Author(s). Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and efficacious then they should be deployed. This is in order to protect and extend the useful therapeutic life of the current generation of anti-malarial drugs, which are so essential for malaria control and elimination. | en_US |
| dc.identifier.citation | Malaria Journal. Vol.18, No.1 (2019) | en_US |
| dc.identifier.doi | 10.1186/s12936-019-2955-z | en_US |
| dc.identifier.issn | 14752875 | en_US |
| dc.identifier.other | 2-s2.0-85072941878 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/51004 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072941878&origin=inward | en_US |
| dc.subject | Immunology and Microbiology | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance | en_US |
| dc.type | Review | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072941878&origin=inward | en_US |